1 . Nearly two years after the COVID-19 outbreak, China has granted approval to its first antibody combination therapy (治疗) for COVID-19 treatment, adding a tool to the world’s fight against the disease.
A team from Tsinghua University, along with the Shenzhen People’s Hospital, has accomplished the task in 20 months. It would usually take 10 years. “It can reduce the rate of hospitalization (住院治疗) and death by 80 percent,” said Zhang Linqi, leader of the research team.
The new antibody drug is immediately effective after being used. Moreover, the therapy can protect people, especially those whose physical condition doesn’t allow vaccination (接种疫苗), from becoming infected by COVID-19 for around 9 to 12 months, said Zhang.
How does it work? When a virus infects a cell, it relies on an important type of protein: the spike proteins (棘突蛋白) on its surface. The spike proteins serve as a key to unlocking a cell. If a virus cannot enter a cell, it will disappear immediately. The job of our antibodies is to block the virus from entering cells. So its target is very precise. In addition, thanks to the coordination between the two antibodies, it is highly efficient in preventing the virus, according to Zhang. The qualities of the new drug make it especially useful for high-risk groups, such as frontline medical workers and people not suitable for vaccination due to various underlying health problems.
The new drug is expected to come to the market soon, but it’s not cheap. That’s because of limited production. Noting that China has used science and technology to fight COVID-19 since the beginning of the outbreak, Zhang said, “Science is the key to solving the issue. Science has shown its power in all sectors, from medical treatment, medicine and vaccine development to prevention and control measures.”
1. What can we know about the new drug according to paragraph 1 and paragraph 2?A.It’s the only way to treat COVID-19. |
B.It dramatically improves the survival rate of patients. |
C.It takes researchers 10 years to develop the new drug. |
D.It was developed by the team from one of China’s top universities. |
A.Only medical workers can take this drug. |
B.Antibodies stop spike proteins entering a cell. |
C.The new medicine takes effect after a period of use. |
D.The new drug can protect people from infection for life. |
A.Doctors and nurses. | B.The elderly and children. |
C.People without vaccination. | D.Patients and their family members. |
A.The drug will be readily available. |
B.The new drug has been put into use. |
C.Zhang had a high regard for the power of science. |
D.China is the first country to use technology to fight disease. |
When the action movie Wolf Warrior II broke China’ s box-office records in 2017, a less prominent (突出的) figure unexpectedly left a strong impression
Two years ago, a real military scientist Dr. Chen Wei
When SARS broke out in China in 2003, Dr. Chen and her team isolated (隔离) the virus and identified (确认) the cause of the disease without delay.
After SARS, the forward-looking woman shifted her attention to Ebola which claimed (夺去生命) over 10,000
From SARS and Ebola to COVID-19, Dr. Chen has spent half of her life fighting against life-threatening viruses.“ We do not have any other choices but
3 . Vaccination(接种疫苗)is among the most effective ways to help us prevent diseases. For viruses that don't change too much-the measles virus(麻疹病毒), for example—getting vaccinated is a once-and-for-all method to prevent you from becoming infected with the virus. If you had two measles vaccines when you were a child, you will be protected for life.
However, it's a different story when it comes to influenza(流行性感冒), commonly known as "the flu", which generally peaks between December and February. Flu vaccines cannot protect us in the long term.
There is no long-term immunity(免疫), according to Theodore Strange, associate medical director at Staten Island University Hospital in New York. "The virus essentially 'changes its coat'—HIN1, H2N3, and so on," he told the website Healthline.
Apart from a person's immune protection from flu vaccination declining over time, flu viruses are also constantly changing. So the vaccines are likely to be updated from one season to the next to protect against the viruses that research suggests may be the most common during the upcoming flu season.
Thus, to develop effective flu vaccines, over 100 national influenza centers around the world conduct year-round surveillance(监测)for influenza. Researchers will test thousands of influenza virus samples from patients, according to the official website of the US Centers for Disease Control and Prevention(CDC). The World Health Organization also suggests there are three or four influenza viruses that are most likely to spread among people during the upcoming flu season.
But even when a vaccine is developed, getting it can prove to be difficult, as it is in high demand and short supply. The timing of influenza vaccine production and distribution is unpredictable, thus the availability of the flu vaccine supply does not always coincide with(与……一致)peak demand.
So scientists prioritize(划分优先顺序)access to the vaccination. The CDC recommends key populations, such as medical staff, teachers, students, children and those aged 60 and above, receive flu vaccines.
This year the situation seems more complicated, as the upcoming flu season coincides with the COVID-19 pandemic. This could overwhelm hospitals, straining(过度使用)resources and healthcare workers' time.
1. What do we know about influenza?A.Influenza viruses are continuously changing. |
B.It commonly peaks between November and December. |
C.Getting two flu vaccines can protect people against the viruses. |
D.HINI and H2N3 are the most easily infectious flu viruses. |
A.They update vaccines once a year. |
B.They monitor the flu throughout the year. |
C.They focus on one or two viruses during a period. |
D.Influenza centers worldwide share virus samples from patients. |
A.Because not all people can afford it. |
B.Because some people refuse to get vaccinated. |
C.Because the vaccine is not safe for everyone. |
D.Because the vaccine doesn't always meet the demand. |
A.It could be more challenging than ever for medical workers. |
B.Enough resources have been prepared to cope with it. |
C.Flu vaccines will be provided for the public in November. |
D.The flu vaccines are expected to help prevent COVID-19. |